CLX-NEU-161

N/A

Report date: 2023/02/18 19:34:52

NME

Base Information

Drug NameCLX-NEU-161

Drug Alias NameCLX-161CLX-CNS-61CLX-NEU-161

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellix Bio Pvt Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsN/A

ATC CodeN/A